BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Menendez JA, Lupu R. Fatty acid synthase: A druggable driver of breast cancer brain metastasis. Expert Opin Ther Targets 2022. [PMID: 35545806 DOI: 10.1080/14728222.2022.2077189] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Polonio-alcalá E, Porta R, Ruiz-martínez S, Vásquez-dongo C, Relat J, Bosch-barrera J, Ciurana J, Puig T. AZ12756122, a novel fatty acid synthase inhibitor, decreases resistance features in EGFR-TKI resistant EGFR-mutated NSCLC cell models. Biomedicine & Pharmacotherapy 2022;156:113942. [DOI: 10.1016/j.biopha.2022.113942] [Reference Citation Analysis]
2 Chu Q, Liu P, Song Y, Yang R, An J, Zhai X, Niu J, Yang C, Li B. Stearate-derived very long-chain fatty acids are indispensable to tumor growth. EMBO J 2023;42:e111268. [PMID: 36408830 DOI: 10.15252/embj.2022111268] [Reference Citation Analysis]
3 Meijuan C, Fang L, Min F, Qian W. Hypomethylated gene RAC3 induces cell proliferation and invasion by increasing FASN expression in endometrial cancer. Int J Biochem Cell Biol 2022;:106274. [PMID: 35917927 DOI: 10.1016/j.biocel.2022.106274] [Reference Citation Analysis]